American College of Allergy, Asthma & Immunology

Articles

For what other indications, and in what regimens, are investigators assessing the drug class?

Thomas Casale, MD: Expanding Biologics

Certain diet-based comorbid conditions are more prevalent in food-allergic patients.

Carina Venter, PhD, RD: Addressing Food Allergy Co-Factors

At least 1 major food allergy trial in recent years has given allergists incentive to set detailed strategies for their patients.

Setting Individual, Tangible Goals in Allergy Care

Could the drug class best serve patients as an adjunctive, a monotherapy, or maybe a prophylaxis for symptoms?

Tina Sindher, MD: Optimal Biologic Use in Allergies

Though research behind preventive measures is lacking, there are common steps that could be taken to reduce pediatric risk.

Setting Expectations in Food Allergy Risk Reduction

As new methods of treatment come to the market, allergists need to ensure their patients are fully informed and able to set their own goals for care.

Douglas Mack, MD: Considering Food Allergy Treatment, Testing Options

Videos

How can physicians train parents to trust immunotherapy&mdash;an allergen exposure they were previously told to avoid?

Douglas Mack, MD: Flipping the Food Allergy Script

A growing patient population and burdens of physician shortage require specialists and primary care collaborate more and more.

David Boone: Getting Primary Care onto the Allergy Team

Assessing a food allergy patient's overall diet during immunotherapy trials could unlock understanding how the microbiome affects the allergic reaction.

Carina Venter, PhD, RD: Gut Microbiome in Food Allergy

Distinguishing biologic-eligible patients may still need further biomarker and disease severity research.

American College of Allergy, Asthma & Immunology

New content coming soon, please check back later.